Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags PEG

Tag: PEG

Novel Linker-Drug Technology Enables Antibody-Drug Conjugates with an Expanded Therapeutic Window

ADC Review | Editorial Team
Preclinical data from a novel, proprietary ADC technology platform being developed by ProfoundBio was being presented at the 2021 Molecular Targets and Cancer Therapeutics...

PEGs and Antibody-drug Conjugates a Versatile Approach

Peter Hofland
Polyethylene Glycol (PEG), sometimes referred to as polyethylene oxide (PEO), consists of repeating ethylene oxide units. Being a nondenaturing water-soluble condensation polymer of ethylene...

AACR 2017: Seattle Genetics Research on Novel PEGylated Glucuronide-MMAE Linker Technology...

Sonia Portillo
With three Antibody Drug Conjugates (ADCs) currently on the market, and more than 40 in clinical trials, there is much interest in research and...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X